EVOME MEDICAL TECHNOLOGIES I (EVMT.CA) Stock Price, Quote, News and Overview
TSX-V:EVMT - TSX Venture Exchange - CA30053H1055 - Common Stock - Currency: CAD
EVMT.CA Quote, Performance and Key Statistics
TSX-V:EVMT (3/7/2025, 7:00:00 PM)
0.08
+0.01 (+6.67%)
The current stock price of EVMT.CA is 0.08 CAD. In the past month the price decreased by -23.81%. In the past year, price decreased by -54.29%.
EVMT.CA Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| PRN.CA | PROFOUND MEDICAL CORP | N/A | 297.70M | ||
| MIR.CA | MEDMIRA INC | N/A | 79.62M | ||
| TLT.CA | THERALASE TECHNOLOGIES INC | N/A | 61.95M | ||
| PINK.CA | PERIMETER MEDICAL IMAGING AI | N/A | 50.50M | ||
| NSCI.CA | NANALYSIS SCIENTIFIC CORP | N/A | 33.97M | ||
| CNVI.CA | CONAVI MEDICAL CORP | N/A | 28.76M | ||
| VPT.CA | VENTRIPOINT DIAGNOSTICS LTD | N/A | 27.68M | ||
| ASG.CA | AURORA SPINE CORP | N/A | 24.90M | ||
| MDX.CA | MEDX HEALTH CORP | N/A | 17.70M | ||
| THRM.CA | THERMA BRIGHT INC | N/A | 15.91M |
Related stock screener links
About EVMT.CA
Company Profile
Evome Medical Technologies, Inc. engages in the provision of financial and consultancy services to the mental health and addiction industry. The company is headquartered in Shirley, New York and currently employs 195 full-time employees. The company went IPO on 2014-03-28. The Company’s products include Biodex Rehab product, Damar Plastics product, Mio-Guard product, Simbex services, and SDP product. Its Biodex Rehab products include Isokinetic Systems, Gait Trainer, Body-Weight Supported Training, Cycles and Ergometers, and Squat-Assist Trainer. Its Mio-Guard products include bags, cases and kits, braces, and supports, diagnostics and instruments, furniture, and equipment, padding and splinting, personal protection, sanitizers and disinfectants, and tapes and wraps. Its applications include fall risk screening and conditioning, patient-driven payment model (PDPM), wellness, sports medicine solutions, neurological involvement, safe patient handling and mobility, and senior living and rehabilitation. The company offers concussion, fall screening and balance assessment and training programs.
Company Info
EVOME MEDICAL TECHNOLOGIES I
49 Natcon Drive
Shirley NEW YORK US
Employees: 200
Company Website: https://www.evomemedical.com/
Investor Relations: https://www.salonaglobal.com/investors
Phone: 18007606826
EVOME MEDICAL TECHNOLOGIES I / EVMT.CA FAQ
What is the stock price of EVOME MEDICAL TECHNOLOGIES I today?
The current stock price of EVMT.CA is 0.08 CAD. The price increased by 6.67% in the last trading session.
What is the ticker symbol for EVOME MEDICAL TECHNOLOGIES I stock?
The exchange symbol of EVOME MEDICAL TECHNOLOGIES I is EVMT and it is listed on the TSX Venture Exchange exchange.
On which exchange is EVMT.CA stock listed?
EVMT.CA stock is listed on the TSX Venture Exchange exchange.
What is EVOME MEDICAL TECHNOLOGIES I worth?
EVOME MEDICAL TECHNOLOGIES I (EVMT.CA) has a market capitalization of 4.81M CAD. This makes EVMT.CA a Nano Cap stock.
How many employees does EVOME MEDICAL TECHNOLOGIES I have?
EVOME MEDICAL TECHNOLOGIES I (EVMT.CA) currently has 200 employees.
What are the support and resistance levels for EVOME MEDICAL TECHNOLOGIES I (EVMT.CA) stock?
EVOME MEDICAL TECHNOLOGIES I (EVMT.CA) has a resistance level at 0.08. Check the full technical report for a detailed analysis of EVMT.CA support and resistance levels.
Is EVOME MEDICAL TECHNOLOGIES I (EVMT.CA) expected to grow?
The Revenue of EVOME MEDICAL TECHNOLOGIES I (EVMT.CA) is expected to decline by -0.65% in the next year. Check the estimates tab for more information on the EVMT.CA EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy EVOME MEDICAL TECHNOLOGIES I (EVMT.CA) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of EVMT.CA, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of EVMT.CA, evaluating the profitability, health, valuation and growth aspects
- EVOME MEDICAL TECHNOLOGIES I (EVMT.CA) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- EVOME MEDICAL TECHNOLOGIES I (EVMT.CA) Sales and EPS estimates to see what analysts future expectations are.
- EVOME MEDICAL TECHNOLOGIES I (EVMT.CA) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- EVOME MEDICAL TECHNOLOGIES I (EVMT.CA) Insider and Institutional Ownership to learn about the owners and their transactions.
- EVOME MEDICAL TECHNOLOGIES I (EVMT.CA) Stock Chart to make your own analysis
- EVOME MEDICAL TECHNOLOGIES I (EVMT.CA) Latest news and press-releases to stay up to date.
Does EVOME MEDICAL TECHNOLOGIES I (EVMT.CA) stock pay dividends?
EVMT.CA does not pay a dividend.
When does EVOME MEDICAL TECHNOLOGIES I (EVMT.CA) report earnings?
EVOME MEDICAL TECHNOLOGIES I (EVMT.CA) will report earnings on 2025-03-25, after the market close.
What is the Price/Earnings (PE) ratio of EVOME MEDICAL TECHNOLOGIES I (EVMT.CA)?
EVOME MEDICAL TECHNOLOGIES I (EVMT.CA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.29).
EVMT.CA Technical Analysis
EVMT.CA Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to EVMT.CA. EVMT.CA has a bad profitability rating. Also its financial health evaluation is rather negative.
EVMT.CA Financial Highlights
Over the last trailing twelve months EVMT.CA reported a non-GAAP Earnings per Share(EPS) of -0.29. The EPS increased by 4.5% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -66.99% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
EVMT.CA Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 80% to EVMT.CA. The Buy consensus is the average rating of analysts ratings from 5 analysts.
For the next year, analysts expect an EPS growth of -400% and a revenue growth -0.65% for EVMT.CA